Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED)

NCT03889886 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

305

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye

Interventions

DRUG: SDP-4 Ophthalmic Solution (0.1%)
DRUG: SDP-4 Ophthalmic Solution (1.0%)
DRUG: SDP-4 Ophthalmic Solution (3.0%)
DRUG: Vehicle

Sponsor

Silk Technologies, Ltd.